August 22, 2024
TOPLINE: Elinzanetant significantly reduced the frequency and severity of vasomotor symptoms in menopausal women by week 12. The drug also improved sleep disturbances and menopause-related quality […]
August 22, 2024
TOPLINE: In patients with small, peripheral non–small cell lung cancer (NSCLC), visceral pleural invasion leads to worse disease-free and recurrence-free survival as well as higher rates […]
August 22, 2024
TOPLINE: Older adults with untreated hypertension have a 36% increased risk for Alzheimer’s disease (AD) compared with those without hypertension and a 42% increased risk for […]
August 22, 2024
TOPLINE: Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for all-cause mortality and major adverse cardiovascular events (MACE) than for dipeptidyl […]
August 22, 2024
TOPLINE: In patients with type 2 diabetes (T2D) and metabolic dysfunction–associated steatotic liver disease (MASLD), the risk for major liver outcomes appears similar with dipeptidyl peptidase […]
August 21, 2024
TOPLINE: Belzutifan demonstrated a significant benefit over everolimus in progression-free survival and objective response rates in advanced renal cell carcinoma. At 18 months, 24% of participants […]
August 21, 2024
TOPLINE: About 4 in 10 cancer cases and close to half of all cancer-related deaths in US adults are associated with potentially modifiable risk factors, including […]
August 21, 2024
TOPLINE: Suicide rates among Asian American youths and young adults vary significantly by ethnic subgroup. Chinese, Filipino, and Indian youths have lower suicide rates than Korean, […]
August 21, 2024
TOPLINE: Treatment with suvorexant was associated with a lower incidence of delirium in hospitalized older adults compared with placebo, but the difference was not statistically significant. […]